Tongxinluo Capsule

The first TCM for treating cardiac & cerebral vascular disease conferred with Second Prize of National Scientific and Technological Progress • Conferred with Second Prize of National Technology Invention • Collected By National Essential Medicine Catalogue • Collected By National Basic Medical Insurance Category A • National-level Key New Product • Necessary Medicine for Emergency Department in TCM Hospitals Tongxinluo Capsule pioneered using collateral disease theory of Traditional Chinese Medicine to treat cardiac and cerebral vascular disease, protect vascular, reduce blood lipid level, anti-inflammation, anti-coagulation; protect vascular endothelium, stably reverse plaque, relieve vasospasm, protect capillary, improve cardiac and cerebral ischemia, which is the basic medicine in preventing and treating ischemic cardiac and cerebral vascular disease. 【Ingredients】 Ginseng Radix et Rhizoma, Hirudo, Scorpio, Paeoniae Rubra Radix, Periostracum Cicadae, Eupolyphaga seu Steleophaga, Scolopendra, Lignum Santali Albi, Lignum Dalbergiae Odoriferae, Oblibanum (processed), Ziziphi Spinosae Semen (stir-baked), Borneolum Syntheticum. 【Indications】 To tonify qi and activate blood, unblock the collaterals to relieve pain. Angina pectoris of coronary heart disease due to heart qi deficiency and static blood obstructing collaterals, manifested as oppression in the chest, localized stabbing or gripping pain, palpitations, spontaneous sweating, shortness of breath, lack of strength, dark purple tongue with static spots, fine, rough pulse, or intermittent pulses; Apoplexy due to qi deficiency and static blood obstructing collaterals, manifested as hemiplegia, hemianesthesia, deviated tongue and mouth, and sluggish speech. 【Clinical Application】 • Reduce blood lipid level, Anti-coagulation, Inhibit thrombosis forming. • Reduce LDL level, Increase HDL level. • Protect vascular endothelium, Inhibit stable plaque, Relieve vasospasm. • Dilate coronary artery; improve myocardial Ischemia; decrease myocardial infarction area; reduce myocardial no-reflow after myocardial infarction reperfusion; inhibit ventricular remodeling. Increase cerebral blood supply, protect the capillary, and improve cerebral ischemia caused by cerebral arteriosclerosis. Treat cerebral infarction; reduce cerebral infarction area; promote nerve function recovery, prevent re-stroke. Protect brain tissue; efficaciously treat vascular dementia, senile dementia. 【Dosage】Take orally, 2 to 4 capsules/time, 3 times/day, 4 weeks for a course of treatment. 【Specification】0.26g/capsule. 【Packing】Blister package, 30 capsules/box, 400boxes/carton. 【MA Number】 License of State Drug Administration Z19980015.